Enveric Biosciences Inc Cash Flow-to-Debt Ratio
Enveric Biosciences Inc cash flow-to-debt ratio. Enveric Biosciences Inc (ENVB) has a Cash Flow-to-Debt Ratio of -2.29x as of September 2025, meaning its operating cash flow of $-2.07 Million could theoretically repay -2% of its total liabilities ($905.88K) in one year. Check Enveric Biosciences Inc (ENVB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Enveric Biosciences Inc (1994–2024)
Cash flow-to-debt ratio of Enveric Biosciences Inc from 1994 to 2024. Historical debt coverage capacity for Enveric Biosciences Inc across 31 annual periods. Check cash flow quality index of Enveric Biosciences Inc to evaluate the quality of earnings relative to operating cash generation.
Enveric Biosciences Inc Cash Flow-to-Debt Ratio by Year (1994–2024)
Enveric Biosciences Inc cash flow-to-debt ratio by year from 1994 to 2024. Year-by-year debt coverage analysis for Enveric Biosciences Inc. For the full cash flow conversion analysis, see ENVB cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.19x | $-7.73 Million | $1.49 Million | ▲ +13.8% |
| 2023 | -6.01x | $-14.09 Million | $2.34 Million | ▼ -40.2% |
| 2022 | -4.29x | $-17.15 Million | $4.00 Million | ▼ -65.3% |
| 2021 | -2.60x | $-11.46 Million | $4.41 Million | ▲ +54.5% |
| 2020 | -5.71x | $-3.89 Million | $681.25K | ▼ -12573.4% |
| 2019 | -0.05x | $-647.86K | $14.38 Million | ▲ +66.9% |
| 2018 | -0.14x | $-2.57 Million | $18.88 Million | ▼ -62.4% |
| 2017 | -0.08x | $-2.74 Million | $32.75 Million | ▲ +13.8% |
| 2016 | -0.10x | $-2.70 Million | $27.84 Million | ▲ +64.1% |
| 2015 | -0.27x | $-3.67 Million | $13.58 Million | ▲ +94.4% |
| 2014 | -4.82x | $-43.16K | $8.96K | ▼ -450.2% |
| 2013 | -0.88x | $-21.63K | $24.70K | ▲ +9.5% |
| 2012 | -0.97x | $-24.85K | $25.67K | ▲ +42.9% |
| 2011 | -1.70x | $-30.35K | $17.89K | ▼ -111.2% |
| 2010 | -0.80x | $-40.67K | $50.64K | ▲ +85.3% |
| 2009 | -5.48x | $-65.04K | $11.87K | ▲ +22.6% |
| 2008 | -7.08x | $-150.19K | $21.21K | ▼ -202.8% |
| 2007 | 6.89x | $329.93K | $47.90K | ▲ +296.0% |
| 2006 | -3.51x | $-305.91K | $87.08K | ▼ -145.8% |
| 2005 | -1.43x | $-256.57K | $179.52K | ▼ -376.9% |
| 2004 | 0.52x | $343.94K | $666.31K | ▲ +150.8% |
| 2003 | -1.02x | $-253.97K | $249.77K | ▼ -478.6% |
| 2002 | 0.27x | $85.14K | $317.01K | ▲ +127.0% |
| 2001 | -0.99x | $-339.68K | $341.54K | ▼ -649.9% |
| 2000 | 0.18x | $145.84K | $806.35K | ▲ +136.7% |
| 1999 | -0.49x | $-665.38K | $1.35 Million | ▲ +59.8% |
| 1998 | -1.22x | $-3.00 Million | $2.45 Million | ▲ +45.7% |
| 1997 | -2.25x | $-3.70 Million | $1.64 Million | ▲ +58.3% |
| 1996 | -5.41x | $-4.72 Million | $873.32K | ▼ -5.2% |
| 1995 | -5.14x | $-3.60 Million | $700.00K | ▼ -478.6% |
| 1994 | -0.89x | $-800.00K | $900.00K | — |